Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Gerodontology ; 29(2): e1103-12, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22260209

RESUMO

OBJECTIVE: To evaluate the efficacy of two new mouthrinses in the reduction of xerostomía-associated symptomatology. BACKGROUND: Xerostomia is a common chronic health condition that affects a great number of adults and significantly deteriorates quality of life, such that treatment is necessary. MATERIALS AND METHODS: Sixty-seven adult subjects of both sexes presenting xerostomia of diverse origin were selected. Mouthrinses were tested using a double-blind, randomized, cross-over clinical trial with an intervining wash out period. RESULTS: The 100% of subjects presented sensation of dry mouth, and 86% stated sensation of thick saliva. Burning tongue sensation, need to drink liquids to swallow and the sensation of swallowing difficulty were recorded in more than 50% of the patients. The most frequent pathologies in the sample were depression, arthritis, and arterial hypertension. Results of the clinical tests showed that mouthrinse 1 relieves sensation of dry mouth, need to drink liquids, and swallowing difficulty. In contrast, mouthrinse 2 relieves only latter two symptoms. Both rinses were more effective in relieving xerostomía-associated symptomatology in patients taking 3 or more medicines simultaneously. CONCLUSION: Both mouthrinses were effective in relieving various xerostomia symptoms, could be distributed at a low cost, thereby improving the quality of life of population affected.


Assuntos
Antissépticos Bucais/uso terapêutico , Xerostomia/prevenção & controle , Adulto , Aloe , Artrite/tratamento farmacológico , Síndrome da Ardência Bucal/prevenção & controle , Cetilpiridínio/análise , Ácido Cítrico/análise , Estudos Cross-Over , Deglutição/efeitos dos fármacos , Transtornos de Deglutição/prevenção & controle , Depressão/tratamento farmacológico , Método Duplo-Cego , Feminino , Aromatizantes/análise , Glicerol/análise , Humanos , Hipertensão/tratamento farmacológico , Masculino , Mentha spicata , Pessoa de Meia-Idade , Antissépticos Bucais/análise , Propilenoglicol/análise , Saliva/efeitos dos fármacos , Saliva/metabolismo , Taxa Secretória/efeitos dos fármacos , Cloreto de Sódio/análise , Fluoreto de Sódio/análise , Língua/efeitos dos fármacos , Resultado do Tratamento , Xilitol/análise
2.
J Affect Disord ; 267: 307-314, 2020 04 15.
Artigo em Inglês | MEDLINE | ID: mdl-32217231

RESUMO

BACKGROUND: Several diagnostic criteria for major depressive disorder (MDE) overlap with those of Chronic Fatigue Syndrome (CFS). Furthermore, atypical MDE (A-MDE), a subtype of MDE characterised by profound fatigue and which has frequently been linked with CFS, exhibits similar low cortisol levels to CFS. However, this result has been only found in specimens designed for measuring acute cortisol levels. In this study, we measure cortisol levels in subjects with CFS and in subjects with A-MDE, without psychiatric comorbidity, using both hair and saliva specimens, to gain a measure of both short and long-term cortisol levels in these two conditions. METHODS: Hair cortisol concentration, representing the cortisol concentration of the previous three months, and salivary cortisol, measured at six time-points across one day and including the cortisol awakening response (CAR), post-awakening delta cortisol and the total daily output, were assessed in an age and gender matched group of 34 controls, 15 subjects with A-MDE and 17 with CFS. RESULTS: CFS (mean 92.2 nmol/l.h, s.d. 33.2 nmol/l.h) and A-MDE (mean 89.1 nmol/l.h, s.d. 22.6 nmol/l.h) subjects both showed lower cortisol total daily output in saliva (AUCg) in comparison to healthy controls (mean 125.5 nmol/l.h, s.d. 40.6 nmol/l.h). However, hair cortisol concentration was not lower than that of controls in either patient group. CFS and A-MDE did not differ from one another on any cortisol measures. CFS subjects reported fewer daily hassles and less severe psychic anxiety symptoms in comparison to A-MDE subjects (all p < 0.05). However, they did not differ in the severity of somatic anxiety symptoms. There was also no difference in the presence of overlapping symptoms such as fatigability and concentration/memory problems between A-MDE and CFS subjects. CONCLUSION: Low levels of cortisol found using short-term measures of daily output may be transient, since cortisol levels were normal when a long-term measure (hair) was studied. This might be explained by a potential cortisol rhythm alteration. Although these disorders have their distinctive depressive and somatic features, they may from part of a wider group of Somatic Symptom Disorders (SSD), given the findings of the same pattern of cortisol secretion in both disorders and increased frequency of overlapping clinical features.


Assuntos
Transtorno Depressivo Maior , Síndrome de Fadiga Crônica , Depressão , Transtorno Depressivo Maior/diagnóstico , Síndrome de Fadiga Crônica/diagnóstico , Humanos , Hidrocortisona , Saliva
3.
Clin Rheumatol ; 33(12): 1707-14, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25085274

RESUMO

Tumor necrosis factor (TNF) plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA). This finding has led to the development of TNF blockers for RA treatment. However, response to these therapies is heterogeneous with success in only two thirds of patient. Some clinical aspects useful in the attempt to predict the response to TNF inhibitors is the promptness and the magnitude of the response at the first weeks and a low basal disease activity, while comorbidities, tobacco, glucocorticoids treatment, and high basal radiological score correlate with a poorer response. The role of TNF promoter polymorphisms in clinical response to anti-TNF therapies is controversial. A correlation between the presence of high baseline titers of rheumatoid factor (RF) and decreased response to anti-TNF treatment has been reported. Most studies show decreased RF titers during anti-TNF treatment mainly in patients who responded to treatment. There is no consensus about the usefulness of basal anti-citrullinated protein antibodies (ACPA) levels, and a decrease in ACPA titers as predictor of clinical response to anti-TNF therapy. Despite some promising markers identified to fulfill this role, currently the predictive value of single markers seems not strong enough to predict treatment response in an individual RA patient.


Assuntos
Artrite Reumatoide/diagnóstico , Artrite Reumatoide/tratamento farmacológico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais Humanizados/administração & dosagem , Artrite Reumatoide/genética , Proteína C-Reativa/metabolismo , Certolizumab Pegol , Citocinas/metabolismo , Etanercepte , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Humanos , Fragmentos Fab das Imunoglobulinas/administração & dosagem , Imunoglobulina G/administração & dosagem , Infliximab , Farmacogenética , Polietilenoglicóis/administração & dosagem , Polimorfismo Genético , Valor Preditivo dos Testes , Prognóstico , Regiões Promotoras Genéticas , Receptores do Fator de Necrose Tumoral/administração & dosagem , Nicotiana/química
4.
Rev. Hosp. Clin. Univ. Chile ; 15(4): 325-331, 2004. tab
Artigo em Espanhol | LILACS | ID: lil-620918

RESUMO

La Arteritis de Células Gigantes (ACG) es una vasculitis frecuente que ocurre en personas mayores y que afecta principalmente vasos craneanos. Generalmente se acompaña de síntomas sistémicos, claudicación mandibular y alteraciones visuales. La Polimialgia Reumática (PMR) se caracteriza por dolor y rigidez de cintura escapular y pelviana que presenta síntomas constitucionales y reacciones sistémicas. En los últimos años, ha aparecido evidencia que relaciona ambas entidades como componentes de una misma enfermedad. En este artículo se revisan aspectos nuevos en diagnóstico, terapia y etiopatogenia de la ACG y sus relaciones con PMR.


The Giant cell arteritis (GCA) is a common vasculitic syndrome occurring in older persons and it preferentially affects cranial arteries. Generally accompanied by constitutional symptoms and typical findings like jaw claudication and vision disorder.Polymyalgia Rheumatica (PMR) is caracterized by pain and stiffness involving shoulder and pelvic girdless with constitutional symptoms and findings of a systemic reaction. In recents years, evidence linking both conditions as components of asingle disease process has been accumulated. In the present article, we review new aspects of the diagnosis, therapy and pathogenesis of the GCA, and their relationship.


Assuntos
Humanos , Masculino , Feminino , Arterite/complicações , Arterite/diagnóstico , Arterite/fisiopatologia , Arterite/terapia , Vasculite/complicações , Dor/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA